Impact of Vancomycin MIC on Clinical Outcomes of Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia Treated with Vancomycin at an Institution with Suppressed MIC Reporting

Methicillin-resistant Staphylococcus aureus (MRSA) is a leading cause of bacteremia and is associated with significant morbidity and mortality. Prior studies evaluating the association of vancomycin MICs with clinical outcomes in patients with MRSA bacteremia have been inconsistent. This study evalu...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Antimicrob Agents Chemother
Hoofdauteurs: Adani, Shaili, Bhowmick, Tanaya, Weinstein, Melvin P., Narayanan, Navaneeth
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society for Microbiology 2018
Onderwerpen:
Clinical Therapeutics
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5913979/
https://ncbi.nlm.nih.gov/pubmed/29378704
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02512-17
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items